XANAMEM
Live / Registered — Registered — Section 71 accepted (as of 25 Aug 2025)
What this means for you
Registered since 06 Oct 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79165819
- Registration number
- 4824580
- Mark type
- Stylized text
- Filed
- 03 Mar 2015
- Published for opposition
- 21 Jul 2015
- Registered
- 06 Oct 2015
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurocognitive disorders including dementia
Owner
- ACTINOGEN LIMITED, Sydney, AU
- ACTINOGEN LIMITED, AU
- ACTINOGEN LIMITED, AU
Prosecution history
- 25 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 25 Aug 2025 — REGISTERED-SEC.71 ACCEPTED
- 25 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 May 2025 — TEAS SECTION 71 RECEIVED
- 20 Feb 2025 — INTERNATIONAL REGISTRATION RENEWED
- 06 Oct 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 15 Feb 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Feb 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 15 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 12 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Aug 2022 — REGISTERED-SEC.71 ACCEPTED
- 11 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL